Fact based stock research
West Pharmaceutical Services (NYSE:WST)


West Pharmaceutical Services stock research in summary

westpharma.com


West Pharmaceutical Services shares have a HOLD rating. While they are safely financed, they show below average growth, and are bad value. We recommend holding West Pharmaceutical Services shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Supplies
Index S&P MIDCAP, D.J. US Medical Equipment
Size class Medium

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock






 

Research History: West Pharmaceutical Services

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
1
18
30
31
STOCK GROWTH RANKS
52
85
63
40
STOCK SAFETY RANKS
94
100
92
73
COMBINED STOCK RANKS
29
73
69
45

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is West Pharmaceutical Services in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of West Pharmaceutical Services; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
45
71
42
34
PROFIT GROWTH
43
90
64
34
STOCK RETURNS
70
82
71
55
CONSOLIDATED RANK: GROWTH
52
85
63
40

Financial reporting date of Growth Rank: 31-Dec-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of West Pharmaceutical Services.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
64
80
58
54
REFINANCING
29
28
LIQUIDITY
100
100
95
98
CONSOLIDATED RANK: SAFETY
94
100
92
73

Financial reporting date of Safety Rank: 31-Dec-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of West Pharmaceutical Services and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for West Pharmaceutical Services from March 22, 2018.